TW255886B - - Google Patents

Info

Publication number
TW255886B
TW255886B TW083103432A TW83103432A TW255886B TW 255886 B TW255886 B TW 255886B TW 083103432 A TW083103432 A TW 083103432A TW 83103432 A TW83103432 A TW 83103432A TW 255886 B TW255886 B TW 255886B
Authority
TW
Taiwan
Prior art keywords
compound
general formula
lower alkyl
cycloalkyl
alkyl
Prior art date
Application number
TW083103432A
Other languages
English (en)
Chinese (zh)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of TW255886B publication Critical patent/TW255886B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
TW083103432A 1993-04-16 1994-04-18 TW255886B (enFirst)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
TW255886B true TW255886B (enFirst) 1995-09-01

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103432A TW255886B (enFirst) 1993-04-16 1994-04-18

Country Status (13)

Country Link
US (1) US5488134A (enFirst)
EP (1) EP0646570B1 (enFirst)
JP (1) JP3411036B2 (enFirst)
KR (1) KR100277242B1 (enFirst)
CN (1) CN1046937C (enFirst)
AT (1) ATE167662T1 (enFirst)
AU (1) AU666819B2 (enFirst)
CA (1) CA2138264C (enFirst)
DE (1) DE69411243T2 (enFirst)
DK (1) DK0646570T3 (enFirst)
ES (1) ES2119190T3 (enFirst)
TW (1) TW255886B (enFirst)
WO (1) WO1994024087A1 (enFirst)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
RU2198885C2 (ru) 1997-09-29 2003-02-20 Мейдзи Сейка Кайся Лтд. Производные трициклического триазолобензазепина, способы их получения, фармацевтическая композиция и способ лечения аллергических заболеваний, промежуточные соединения и способы их получения
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
EP1140190B1 (en) 1998-12-23 2002-11-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
ATE240120T1 (de) 1998-12-23 2003-05-15 Searle Llc Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
IL143949A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
DK1140185T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
WO2000038726A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
US20020061888A1 (en) * 2000-03-10 2002-05-23 Keller Bradley T. Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
JP2005518347A (ja) 2001-11-02 2005-06-23 ジー.ディー. サール エルエルシー 頂端ナトリウム共依存性胆汁酸輸送(asbt)およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
BR0306643A (pt) 2002-01-17 2004-10-19 Pharmacia Corp Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
US20140323412A1 (en) 2011-10-28 2014-10-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
SG10201909122QA (en) 2011-10-28 2019-11-28 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
CA2907214A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
JP7562546B2 (ja) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0701991T3 (da) * 1991-10-17 1999-09-13 Shionogi & Co Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Also Published As

Publication number Publication date
ES2119190T3 (es) 1998-10-01
JP3411036B2 (ja) 2003-05-26
AU6437994A (en) 1994-11-08
KR950701902A (ko) 1995-05-17
KR100277242B1 (ko) 2001-02-01
DE69411243T2 (de) 1998-11-19
CA2138264A1 (en) 1994-10-27
DE69411243D1 (de) 1998-07-30
EP0646570A1 (en) 1995-04-05
US5488134A (en) 1996-01-30
AU666819B2 (en) 1996-02-22
CN1046937C (zh) 1999-12-01
CN1109685A (zh) 1995-10-04
EP0646570A4 (en) 1995-08-09
ATE167662T1 (de) 1998-07-15
WO1994024087A1 (fr) 1994-10-27
CA2138264C (en) 2004-04-06
EP0646570B1 (en) 1998-06-24
DK0646570T3 (da) 1998-10-26

Similar Documents

Publication Publication Date Title
TW255886B (enFirst)
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
AU6326890A (en) Improvements in or relating to organic compounds
TW223645B (enFirst)
AU1120095A (en) Novel imidazole derivative and process for producing the same
EP0554455A4 (enFirst)
AU2722095A (en) Novel pyrrolocarbazoles
GR3025599T3 (en) the same Carbazolone derivatives and process for preparing
GR3006060T3 (enFirst)
AU8460791A (en) Compound, preparation and use
EP0601191A4 (en) Novel tetracyclic compound.
AU2406097A (en) Process for the preparation of tetrahydro-indolizines
IL119331A0 (en) Method for preparing alpha, beta-unsaturated-beta-trifluoromethyl carboxylates and related compounds
GR3032474T3 (en) Selective dehalogenation method
EP0331073A3 (en) Benzhydrylamine derivatives
GR3034291T3 (en) Catalyst with improved activity for ethylene (co)-polymerization
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
GR3004216T3 (enFirst)
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
GR3021427T3 (en) Indole derivative
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS
HU902609D0 (en) Process for the preparation of 2-cyclohexenyl-carboxylates
AU4340793A (en) Benzopyran derivative, production thereof, and pharmaceutical preparation containing the same as active ingredient

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees